Moderna's RSV shot is the first messenger RNA-based (mRNA) vaccine not for COVID-19 to be approved in the United States. It ...
The US Food and Drug Administration approved Cambridge, Massachusetts-based Moderna’s vaccine for a respiratory virus which ...
The OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.
Cambridge: Moderna, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), an ...
Moderna reported better-than-expected 1Q24 revenue of $167 million and its pipeline looks promising. Read my earnings ...
Novavax's updated vaccine targets a variant called JN.1, which is in line with European recommendations. The European Union's ...
Guillain-Barre Syndrome 'More Common Than Expected' With RSV Vaccine in Older People, CDC Reiterates NEW YORK (AP) — Reports ...
Moderna Chief Executive Officer Stéphane Bancel talks about how the biotech giant is cutting costs and developing new vaccines. The drugmaker expects to have its vaccine for respiratory syncytial ...
The U.S. Food and Drug Administration on Wednesday approved the expanded use of Bristol Myers Squibb's cancer cell therapy Breyanzi to include the treatment of adults with a type of blood cancer that ...
This article discusses Donald Trump convicted on 34 charges of falsifying business records, the upcoming PCE data, Boeing's ...
Get complete access for 24 hours to all of the content on our site, including breaking news, e-editions, archives (2010 to current) and special sections. Add 3 Months Online Service to my Home ...